Desvenlafaxine
- Product NDC
- 51407-023
- 11-digit product format
- 514070023
- Labeler code
- 51407
- Product ID
- 51407-023_e2215c75-906a-5805-e053-2995a90a2d7e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Desvenlafaxine
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Golden State Medical Supply, Inc.
- Application
- ANDA204065
- Marketing category
- ANDA
- Marketing start
- 2016-07-29
- Marketing end
- 0000-00-00
- Substance
- DESVENLAFAXINE SUCCINATE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51407-023-90 | 51407002390 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (51407-023-90) | 2018-01-01 | 0000-00-00 | No | No | Current |